Learn about two types of health insurance models that insurers are implementing to encourage consumers to take a more active role in their health, and find out which model is more effective and why.
Families USA submitted the attached letter to U.S. House of Representatives Leadership in support of H.R. 987, the Strengthening Health Care and Lowering Prescription Drug Costs Act.
Live updates from day 2 of Health Action 2014.
The Medicare Access and CHIP Reauthorization Act (MACRA) is the biggest change to how Medicare pays for services in decades. It will accelerate the movement towards value-based payments—where what health care providers get paid depends, at least partially, on the quality of care they provide, not just the volume of services. On June 27, Families USA submitted comments about how the law will be implemented.
Defines what quality health care is and explains why measuring health care quality is important. Discusses five ways that quality measurement can improve health care.
Quality measurement uses data to evaluate the performance of health plans and providers. Learn how the health care field is using this data to measure and improve the quality of health care that patients receive.
By now the benefits of Medicaid expansion are well known. In addition to providing health coverage to millions of Americans, it has helped create new health care jobs, decrease hospitals’ spending on uncompensated care, and generate budget savings for states. But another benefit is often overlooked: Medicaid expansion can help improve the quality of health care and reduce costs throughout a state’s entire health care system, not just in Medicaid.
Early last week, Health and Human Services Secretary Sylvia Burwell announced a new initiative designed to support state efforts to improve the health of Medicaid beneficiaries and the care they receive.
As part of the Medicaid Innovation Accelerator Program (IAP), the Center for Medicare Services (CMS) will develop new resources for and provide technical assistance to states engaged in efforts to reform their Medicaid programs. The IAP seeks to achieve the triple aim of better care, better health outcomes, and lower costs.
As drug prices continue to rise at an unsustainable rate, we must ensure that our health care system and its financial incentives enhance the quality and value of care. We believe the Medicare Part B prescription drug model proposed by the Centers for Medicare & Medicaid Services (CMS) creates value for the patient and the program by encouraging treatment choices that have been shown to improve care and health outcomes.